Optimization of experimental conditions for RNA-based sequencing of MLH1 and MSH2 genes

被引:0
|
作者
Jakubowska, A
Górski, B
Kurzawski, G
Debniak, T
Hadaczek, P
Cybulski, C
Kladny, J
Oszurek, O
Scott, RJ
Lubinski, J
机构
[1] Pomeranian Acad Med, Dept Genet & Pathol, PL-70115 Szczecin, Poland
[2] Pomeranian Acad Med, Dept Surg 3, Szczecin, Poland
[3] Univ Newcastle, Discipline Med Genet, Newcastle, NSW 2308, Australia
关键词
MLH1; MSH2; RNA-based sequencing; reverse transcription; mutation detection; RT-PCR; mismatch repair; HNPCC;
D O I
10.1002/1098-1004(2001)17:1<52::AID-HUMU6>3.0.CO;2-E
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The most sensitive technique for the detection of germline mutations is er;on by exon sequencing of the gene under investigation using genomic DNA as a template for analysis. This approach, however, has cost and sensitivity limitations that can, at least in part, be overcome by RNA-based analysis. Germline mutations of MLH1 and MSH2 are the most frequent cause of the inherited susceptibility to colorectal and other epithelial cancers known as hereditary non-polyposis colorectal cancer (HNPCC). We compared the analysis of the MLH1 and MSH2 genes using mRNA and genomic DNA. as starting material from 21 HNPCC patients. All samples mere investigated by RT-PCR, sequencing of cDNA and simultaneous sequencing of genomic DNA. The cDNA was generated using specific primers complementary to the ends of MLH1 and MSH2 genes, respectively Mutations in MLH1 and MSH2 were detected in 11 out of 21 unrelated patients. In 10 out of 11 cases, mutations were detected independently of the type of primers used for reverse transcription (RT). One novel missense mutation (K751R) in MLH1 was detected using this method. One nonsense mutation (E205X) in MSH2 was only detectable when RT was performed using MSH2 gene-specific printers. Shorter PCR products indicative of alternatively spliced transcripts were not observed when MLH1 or MSH2 specific cDNA RT primers were employed to generate template, except in one case where exon skipping was observed for exons 9 and 10. In this report we demonstrate that primers specific for RT of MLH1 and MSH2 are crucial for increasing the sensitivity of cDNA analysis. DNA sequencing using RNA as a basis for template construction may be a valuable and economical alternative to genomic DNA sequencing. Hum Mutat 17:52-60, 2001. (C) 2001 Wiley-Liss, Inc.
引用
收藏
页码:52 / 60
页数:9
相关论文
共 50 条
  • [1] MSH2 and MLH1 testing
    Grzegorz Kurzawski
    Janina Suchy
    Jan Lubiński
    Hereditary Cancer in Clinical Practice, 6
  • [2] MSH2 and MLH1 testing
    Kurzawski, Grzegorz
    Suchy, Janina
    Lubinski, Jan
    HEREDITARY CANCER IN CLINICAL PRACTICE, 2008, 6 (02) : 83 - 83
  • [3] MLH1 and MSH2 expression in pterygia
    Schneider, Barbara G.
    Sahni, Deshdeepak
    Torres, Juan C.
    Dushku, Nicholas
    Reid, Ted W.
    CORNEA, 2007, 26 (04) : 468 - 472
  • [4] Mutations in MLH1 and MSH2 genes and impairment of the DNA repair pathway
    Thodi, G.
    Fostira, F.
    Sandaltzopoulos, R.
    Nasioulas, G.
    Yannoukakos, D.
    FEBS JOURNAL, 2008, 275 : 197 - 197
  • [5] Novel Mutations in MLH1 and MSH2 Genes in Mexican Patients with Lynch Syndrome
    Miguel Moreno-Ortiz, Jose
    de la Luz Ayala-Madrigal, Maria
    Roman Corona-Rivera, Jorge
    Centeno-Flores, Manuel
    Maciel-Gutierrez, Victor
    Antonio Franco-Topete, Ramon
    Armendariz-Borunda, Juan
    Hotchkiss, Erin
    Perez-Carbonell, Lucia
    Rhees, Jennifer
    Boland, Clement Richard
    Gutierrez-Angulo, Melva
    GASTROENTEROLOGY RESEARCH AND PRACTICE, 2016, 2016
  • [6] Partial duplications of the MSH2 and MLH1 genes in hereditary nonpolyposis colorectal cancer
    Stephanie Baert-Desurmont
    Marie-Pierre Buisine
    Emilie Bessenay
    Stephanie Frerot
    Tonio Lovecchio
    Cosette Martin
    Sylviane Olschwang
    Qing Wang
    Thierry Frebourg
    European Journal of Human Genetics, 2007, 15 : 383 - 386
  • [7] Partial duplications of the MSH2 and MLH1 genes in hereditary nonpolyposis colorectal cancer
    Baert-Desurmont, Stephanie
    Buisine, Marie-Pierre
    Bessenay, Emilie
    Frerot, Stephanie
    Lovecchio, Tonio
    Martin, Cosette
    Olschwang, Sylviane
    Wang, Qing
    Frebourg, Thierry
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2007, 15 (03) : 383 - 386
  • [8] Cancer Risks for MLH1 and MSH2 Mutation Carriers
    Dowty, James G.
    Win, Aung K.
    Buchanan, Daniel D.
    Lindor, Noralane M.
    Macrae, Finlay A.
    Clendenning, Mark
    Antill, Yoland C.
    Thibodeau, Stephen N.
    Casey, Graham
    Gallinger, Steve
    Le Marchand, Loic
    Newcomb, Polly A.
    Haile, Robert W.
    Young, Graeme P.
    James, Paul A.
    Giles, Graham G.
    Gunawardena, Shanaka R.
    Leggett, Barbara A.
    Gattas, Michael
    Boussioutas, Alex
    Ahnen, Dennis J.
    Baron, John A.
    Parry, Susan
    Goldblatt, Jack
    Young, Joanne P.
    Hopper, John L.
    Jenkins, Mark A.
    HUMAN MUTATION, 2013, 34 (03) : 490 - 497
  • [9] Prediction of MLH1 and MSH2 mutations in Lynch syndrome
    Balmana, Judith
    Stockwell, David H.
    Steyerberg, Ewout W.
    Stoffel, Elena M.
    Deffenbaugh, Amie M.
    Reid, Julia E.
    Ward, Brian
    Scholl, Thomas
    Hendrickson, Brant
    Tazelaar, John
    Burbidge, Lynn Anne
    Syngal, Sapna
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 296 (12): : 1469 - 1478
  • [10] Expressional analysis of MLH1 and MSH2 in breast cancer
    Malik, Saima Shakil
    Masood, Nosheen
    Asif, Muhammad
    Ahmed, Parvez
    Shah, Zafar Ullah
    Khan, Jahangir Sarwar
    CURRENT PROBLEMS IN CANCER, 2019, 43 (02) : 97 - 105